Cutaneous melanoma: Population-based study in Goiania, Brazil, from 1988 to 2000

Anais Brasileiros de Dermatologia

Volumn 81, Issue 5, 2006, Pages 449-455

  Sortino Rachou, Ana Maria ^a,b,c,d,g   Curado, Maria Paula ^a,e   Latorre, Maria Do Rosário Dias De Oliveira ^f  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b Sociedade Brasileira de Cirurgia Dermatológica   (Brazil)

^c Grupo Brasileiro de Melanoma (GBM)   (Brazil)

^d American Academy of Dermatology (AAD)   (United States)

^e Goiania Cancer Registry   (Brazil)

^f UNIVERSITY OF SÃO PAULO   (Brazil)

^g NONE   (Brazil)

Author keywords

Brazil; Melanoma; Melanoma epidemiology; Melanoma mortality; Skin

Indexed keywords

ADULT; AGED; BRAZIL; CANCER REGISTRY; CONFERENCE PAPER; CONTROLLED STUDY; FEMALE; GROUPS BY AGE; HUMAN; INCIDENCE; LINEAR REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORTALITY; POPULATION RESEARCH; SEX DIFFERENCE;

EID: 34248671954     PISSN: 03650596     EISSN: 18064841     Source Type: Journal    
DOI: 10.1590/s0365-05962006000500007     Document Type: Conference Paper

References (26)

1. Hanahan D, Weinberg RA. The hallmarks of cancer. Cell. 2000;100:57-70.
2. Peto J. Cancer epidemiology in the last century and the next decade. Nature. 2001;411:390-5.
3. Desmond RA, Soong S. Epidemiology of malignant melanoma. Surg Clin North Am. 2003;83:1-29.
4. Cancer incidence in five continents. IARC Sci Publ. 1997;VII:i-xxxiv, 1-1240.
5. Tracey E, Roder D, Bishop J, Chen S, Chen W. Cancer in New South Wales incidence and mortality 2003.[homepage on the Internet]. Australia: Cancer Institute NSW. [updated 2005 May; cited 2005 Dec 28]. Available from: http://www.cancerinstitute.org.au/cancer_inst/statistics/pdfs/ IncidenceMortalityReport2005.pdf
6. Leite M. Raças, genes e homens. Folha de São Paulo (Cadernos). 28 Jan 2003; 3:20-2.
7. Johnson DS, Yamane S, Morita S, Yonehara C, Wong JH. Malignant melanoma in non-Caucasians: experience from Hawaii. Surg Clin North Am. 2003;83:275-82.
8. Bulliard JL, Cox B. Cutaneous malignant melanoma in New Zealand: trends by anatomical site, 1969-1993. Int J Epidemiol. 2000;29:416-23.
9. Marrett LD, Nguyen HL, Armstrong BK. Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983-1996. Int J Cancer. 2001;92:457-62.
10. MacKie RM. The incidence of and survival from malignant melanoma in Scotland: an epidemiological study. Lancet. 2002;360:587-91.
11. De Vries E, Schouten LJ, Visser O, Eggermont AM, Coebergh JW, Working Group of Regional Cancer Registries. Rising trends in the incidence of and mortality from cutaneous melanoma in the Netherlands: a Northwest to Southeast gradient? Eur J Cancer. 2003;39:1439-46.
12. Newnham A, Moller H. Trends in the incidence of cutaneous malignant melanomas in the south east of England, 1960-1998. J Public Health Med. 2002;24:268-75.
13. De Vries E, Bray FI, Coebergh JW, Parkin DM. Changing epidemiology of malignant cutaneous melanoma in Europe 1953-1997: rising trends in incidence and mortality but recent stabilizations in Western Europe and decreses in Scandinavia. Int J Cancer. 2003;107:119-26.
14. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001;93:678-83.
15. Sortino AMF. Melanoma cutâneo em Goiânia: tendências de incidência e mortalidade, 1988-2000 [dissertação]. São Paulo: Fundação Antonio Prudente; 2003. 98 f.
16. Czarnecki D, Meehan CJ. Is the incidence of malignant melanoma decreasing in young Australians? J Am Acad Dermatol. 2000;42:672-4.
17. World Health Organization (WHO) [database on the internet]. Lyon: International Agency for research on cancer. [updated 2005 Oct, cited 2006 Mar 22]. Available from: http://www-dep.iarc.fr
18. Severi G, Giles GG, Robertson C, Boyle P, Autier P. Mortality from cutaneous melanoma: evidence for contrasting trends between populations. Br J Cancer. 2000;82:1887-91.
19. Jemal A, Devesa SS, Fears TR, Hartge P. Cancer surveillance series: changing patterns of cutaneous malignant melanoma mortality rates among whites in the United States. J Natl Cancer Inst. 2000;92:811-8.
20. La Vecchia C, Lucchini F, Negri E, Levi F. Recent declines in worldwide mortality from cutaneous melanoma in youth and middle age. Int J Cancer. 1999;81:62-6.
21. Giles GG, Armstrong BK, Burton RC, Staples MP, Thursfield VJ. Has mortality from melanoma stopped rising in Australia? Analysis of trends between 1931 and 1994. BMJ. 1996;312:1121-5.
22. Garbe C, Roderick G, McLeod C, Buettner PG. Time trends of cutaneous melanoma in Queensland, Australia and Central Europe. Cancer. 2000;89:1269-78.
23. Houghton NA, Polsky D. Focus on melanoma. Cancer Cell. 2002;2:275-8.
24. Bulliard JL, Cox B, Elwood JM. Comparison of the site distribution of melanoma in New Zealand and Canada. Int J Cancer. 1997;72:231-5.
25. Schmid-Wendtner MH, Baumert J, Stange J, Volkenandt M. Delay in the diagnosis of cutaneous melanoma: an analysis of 233 patients. Melanoma Res. 2002;12:389-94.
26. Jensen OM, Storm HH. Purposes and uses of cancer registration. In: Jensen OM, Parkin DM, Maclennan R, Muir CS, Skeet RG. Cancer registration: principles and Methods. IARC Sci Publ. 1991;95:7-21.